0001203311-16-000086.txt : 20160519 0001203311-16-000086.hdr.sgml : 20160519 20160519151428 ACCESSION NUMBER: 0001203311-16-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160517 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 161662905 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-05-17 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001167496 SIEGALL CLAY B 21823 30TH DRIVE SE BOTHELL WA 98021 1 1 0 0 President and CEO Common Stock 2016-05-17 4 M 0 7618.0 4.45 A 563733 D Common Stock 2016-05-17 4 S 0 7618.0 35.16 D 556115 D Common Stock 27945 I by Trust Non-Qualified Stock Option (right to buy) 4.45 2016-05-17 4 M 0 7618.0 0.0 D 2016-09-05 Common Stock 7618 30465 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan. Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares vested at a rate of 25% on 9/06/07 and monthly thereafter until all the shares were fully vested on 9/06/10. /s/ Clay B. Siegall 2016-05-19